Timber Hill’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,616
Closed -$221K 728
2017
Q2
$221K Sell
5,616
-13,254
-70% -$484K 0.01% 829
2017
Q1
$592K Sell
18,870
-2,700
-13% -$84.5K ﹤0.01% 1383
2016
Q4
$674K Buy
+21,570
New +$699K ﹤0.01% 1497
2016
Q1
Sell
-17,520
Closed -$483K 2151
2015
Q4
$461K Sell
17,520
-27,246
-61% -$708K ﹤0.01% 1737
2015
Q3
$1.06M Buy
44,766
+10,086
+29% +$243K ﹤0.01% 1374
2015
Q2
$823K Buy
34,680
+19,044
+122% +$430K ﹤0.01% 1626
2015
Q1
$371K Sell
15,636
-20,688
-57% -$464K ﹤0.01% 1944
2014
Q4
$771K Buy
+36,324
New +$730K ﹤0.01% 1618

Other funds holding EW

Timber Hill's EW Position: Q3 2017 in Review

Timber Hill sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 5,616 shares — an estimated $221K sold.

Timber Hill first reported a position in EW in Q4 2014 and held it in 8 quarters. The position peaked at $1.06M in Q3 2015. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

  • Timber Hill reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
  • Timber Hill sold 5,616 Edwards Lifesciences shares in Q3 2017, an estimated $221K.
  • Timber Hill first reported a position in Edwards Lifesciences in Q4 2014 and held it in 8 quarters.
  • Timber Hill's Edwards Lifesciences position peaked at $1.06M in Q3 2015.
  • 740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Timber Hill's 13F filing for Q3 2017, filed 7 Nov 2017.